Page last updated: 2024-10-26

thiorphan and Goldblatt Syndrome

thiorphan has been researched along with Goldblatt Syndrome in 1 studies

Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pham, I1
Gonzalez, W1
el Amrani, AI1
FourniƩ-Zaluski, MC1
Philippe, M1
Laboulandine, I1
Roques, BP1
Michel, JB1

Other Studies

1 other study available for thiorphan and Goldblatt Syndrome

ArticleYear
Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Desoxycorticosterone; Diuresis; E

1993